Jung-Won Woo
Chief Executive Officer at GENEXINE, INC.
Network origin in Jung-Won Woo first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 15 | |
Public Company | Biotechnology | 13 | |
Public Company | Medical Distributors | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jung-Won Woo via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Pohang University of Science & Technology | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
HANDOK INC. | Pharmaceuticals: Other | Chief Executive Officer Director of Finance/CFO | |
Yonsei University | College/University | Undergraduate Degree Undergraduate Degree | |
McGill University | College/University | Masters Business Admin Doctorate Degree | |
REZOLUTE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chief Tech/Sci/R&D Officer | |
University of Wisconsin | College/University | Doctorate Degree | |
SAMYUNG ENC CO., LTD. | Telecommunications Equipment | Director/Board Member | |
Korean Society For Molecular & Cellular Biology | Director/Board Member | ||
University of Florida | College/University | Doctorate Degree | |
Korean Society of Virology | Corporate Officer/Principal | ||
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Genexine, Inc. (New York)
Genexine, Inc. (New York) BiotechnologyHealth Technology Part of Genexine, Inc., Genexine, Inc. (New York) is a private company that manufactures biological products. The company is based in New York, NY. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Purdue University | College/University | Doctorate Degree | |
CHONG KUN DANG PHARMACEUTICAL CORP. | Pharmaceuticals: Major | Chief Executive Officer | |
Northern Illinois University | College/University | Doctorate Degree | |
PT Kalbe Genexine Biologics
PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan. | Biotechnology | Chief Operating Officer | |
The University of Chicago | College/University | Doctorate Degree | |
Bj Kang Law PC | Founder | ||
OCI HOLDINGS COMPANY LTD. | Chemicals: Specialty | Director/Board Member | |
Catholic University of Korea | College/University | Corporate Officer/Principal | |
Illinois State University | College/University | Graduate Degree | |
Chungnam National University | College/University | Graduate Degree | |
Rush University | College/University | Doctorate Degree | |
SL Bigen Co. Ltd. | Chief Executive Officer | ||
OCI COMPANY LTD. | Chemicals: Major Diversified | Director/Board Member | |
DONG-A ST CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Johnson & Johnson Korea Ltd.
Johnson & Johnson Korea Ltd. Household/Personal CareConsumer Non-Durables Johnson & Johnson Korea Ltd. engages in the manufacture of perfumes and cosmetics. The company was founded on May 28, 1983 and is headquartered in Seoul, South Korea. | Household/Personal Care | Chief Executive Officer | |
Syracuse University College of Law | College/University | Graduate Degree | |
The University of Texas at Austin | College/University | Undergraduate Degree | |
Korea University | College/University | Undergraduate Degree | |
MEDIPOST CO., LTD. | Other Transportation | Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
Korean Association of Immunobiologists | President | ||
Kelley School of Business | College/University | Masters Business Admin | |
pH Pharma Co., Ltd.
pH Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology pH Pharma Co. Ltd. engages in the developing and manufacturing of bio-pharmaceuticals. Its products include php-303, php-201, ab-101, nuvesse, alpine and torpedo products. The company was founded by Ho Young Huh on September 22, 2015 and is headquartered in Seoul, South Korea. | Pharmaceuticals: Major | Director/Board Member | |
Sanofi-Aventis Korea Co., Ltd.
Sanofi-Aventis Korea Co., Ltd. Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Korea Co., Ltd. provides pharmaceutical research and development services. Its products include prescription medicine, consumer health care, vaccines, and non-prescription medicine. The company founded in April 1991 and is headquartered in Seoul, South Korea. | Pharmaceuticals: Major | Chief Executive Officer | |
The Korea Chamber of Commerce & Industry
The Korea Chamber of Commerce & Industry Miscellaneous Commercial ServicesCommercial Services The Korea Chamber of Commerce & Industry (KCCI) is a business organization that provides resources, publications, events, and networks for its members. The organization is based in Seoul, North Korea and has overseas offices. The KCCI advocates for its members and partners with other organizations to promote bilateral economic cooperation. The KCCI also provides economic data and policy issues publications and hosts business forums and roundtables. Recently, the KCCI hosted a successful business forum with over 600 attendees, including political and business leaders from both countries. The Financial Services Commission identified five bank holding companies and five banks as domestic systemically important banks for 2024, and those identified as D-SIBs are required to set aside an additional common equity capital of 1.0, and the higher loss absorbency requirement will take effect on January 1, 2024. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Handok Jeseok Foundation | President | ||
TRIGR Therapeutics, Inc.
TRIGR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trigr Therapeutics, Inc. engages in pharmaceuticals industry group. The company is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member | |
Korea Hoechst Marion Roussel | Chief Executive Officer | ||
Korea Pharmaceutical Manufacturers Association | Director/Board Member | ||
Korean German Society | President | ||
Korean German Chamber of Commerce & Industry | Director/Board Member | ||
Hoechst Marion Roussel, Inc. | Chief Executive Officer | ||
University of Toronto | College/University | Undergraduate Degree |
Statistics
International
South Korea | 26 |
United States | 19 |
Canada | 3 |
Germany | 3 |
France | 2 |
Sectoral
Consumer Services | 19 |
Health Technology | 12 |
Process Industries | 4 |
Electronic Technology | 3 |
Miscellaneous | 2 |
Operational
Director/Board Member | 37 |
Corporate Officer/Principal | 18 |
Chief Executive Officer | 16 |
Doctorate Degree | 11 |
President | 11 |
Most connected contacts
Insiders | |
---|---|
Neil Warma | 15 |
Young-Jin Kim | 15 |
Mi-Jung Ahn | 9 |
Young-Chul Sung | 9 |
Se-Hwan Yang | 5 |
Peter N. Laivins | 4 |
Kyu-Don Kim | 4 |
Jin-Geon Bae | 4 |
Byung-ha Lee | 3 |
Gene Namgoong | 3 |
Luke Oh | 3 |
Hyi-Jeong Ji | 3 |
Soo-Hyoung Kang | 2 |
Byoung-Jo Kang | 2 |
Yu-Seok Seo | 2 |
- Stock Market
- Insiders
- Jung-Won Woo
- Company connections